News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,237 Results
Type
Article (41838)
Company Profile (329)
Press Release (663070)
Section
Business (210146)
Career Advice (2075)
Deals (36572)
Drug Delivery (96)
Drug Development (82801)
Employer Resources (171)
FDA (16478)
Job Trends (15357)
News (355409)
Policy (33819)
Tag
Academia (2574)
Alliances (51090)
Alzheimer's disease (1247)
Approvals (16409)
Artificial intelligence (141)
Bankruptcy (362)
Best Places to Work (11672)
Biotechnology (214)
Breast cancer (122)
Cancer (1110)
Cardiovascular disease (102)
Career advice (1737)
Cell therapy (238)
Clinical research (65790)
Collaboration (395)
Compensation (202)
COVID-19 (2601)
C-suite (96)
Data (1135)
Diabetes (154)
Diagnostics (6225)
Earnings (86506)
Employer resources (149)
Events (112343)
Executive appointments (318)
FDA (17026)
Funding (359)
Gene therapy (188)
GLP-1 (611)
Government (4445)
Healthcare (18853)
Infectious disease (2686)
Inflammatory bowel disease (110)
Interviews (319)
IPO (16580)
Job creations (4051)
Job search strategy (1487)
Layoffs (435)
Legal (8318)
Lung cancer (172)
Manufacturing (185)
Medical device (13260)
Medtech (13265)
Mergers & acquisitions (20065)
Metabolic disorders (420)
Neuroscience (1531)
NextGen Class of 2024 (6625)
Non-profit (4513)
Northern California (1489)
Obesity (242)
Opinion (204)
Patents (105)
People (58244)
Pharmaceutical (92)
Phase I (20347)
Phase II (28953)
Phase III (21718)
Pipeline (460)
Postmarket research (2644)
Preclinical (8679)
Radiopharmaceuticals (241)
Rare diseases (229)
Real estate (6240)
Regulatory (22368)
Research institute (2358)
Resumes & cover letters (358)
Southern California (1309)
Startups (3712)
United States (13673)
Vaccines (568)
Weight loss (183)
Date
Today (82)
Last 7 days (690)
Last 30 days (3765)
Last 365 days (36251)
2024 (33270)
2023 (40631)
2022 (51799)
2021 (56335)
2020 (54799)
2019 (47406)
2018 (35773)
2017 (33140)
2016 (32669)
2015 (38618)
2014 (32519)
2013 (27632)
2012 (29736)
2011 (30487)
2010 (28498)
Location
Africa (776)
Arizona (199)
Asia (39995)
Australia (6397)
California (3356)
Canada (1301)
China (257)
Colorado (150)
Connecticut (156)
Europe (85157)
Florida (462)
Georgia (116)
Illinois (348)
Indiana (204)
Kansas (96)
Maryland (581)
Massachusetts (2653)
Michigan (159)
Minnesota (274)
New Jersey (972)
New York (968)
North Carolina (720)
Northern California (1489)
Ohio (139)
Pennsylvania (852)
South America (1157)
Southern California (1309)
Texas (475)
Washington State (369)
705,237 Results for "halo pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Masimo Announces Sleep Halo™, Advanced Sleep Analysis for the Masimo W1®
Masimo, announced that the Masimo W1® Sport advanced health tracking wearable is gaining a powerful new feature: scientifically based sleep analysis with Sleep Halo™.
July 1, 2024
·
9 min read
FDA
Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform
Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.
May 8, 2024
·
4 min read
Business
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
Nexalin Technology, Inc. announces that the U.S. Food and Drug Administration has provided feedback and reached consensus on the design for its planned clinical studies in anxiety and insomnia for its new Gen-3 HALO Clarity™, a non-invasive, Deep Intracranial Frequency Stimulation headset device designed to address the global mental health epidemic.
June 3, 2024
·
5 min read
Press Releases
The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP to Deliver AI-enabled Diagnostics
October 31, 2024
·
4 min read
Lone Star Bio
Nexalin Technology Unveils Next-Generation HALO™ Clarity
Nexalin Technology, Inc. today unveiled its Gen-3 HALO™ Clarity 15 milliamp (mA) neurostimulation device designed to treat a variety of mental health conditions, including Major Depressive Disorder (MDD).
January 11, 2024
·
5 min read
Press Releases
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
October 23, 2024
·
6 min read
BioCapital
Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
Noramco announced its launch of the Noramco Group, a newly created comprehensive North American-based supply chain solution including subsidiaries Purisys, Noramco, and the newly acquired drug product CDMO, Halo Pharma.
March 14, 2024
·
6 min read
Pharm Country
Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner
Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.
May 22, 2024
·
4 min read
Drug Development
Ionis announces webcast to report HALOS study results for ION582 in Angelman syndrome
July 8, 2024
·
1 min read
Press Releases
Indica Labs Announces Suite of HALO AI Apps to Power Life Sciences Image Analysis Workflows
August 15, 2024
·
3 min read
1 of 70,524
Next